Cargando…

Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression

BACKGROUND: There is growing evidence that indicates the presence of a prothrombotic state in atrial fibrillation (AF). However, the role of hemostatic markers in AF remains inconclusive. METHODS: We conducted a meta-analysis of observational studies to evaluate the association between hemostatic ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Na, Tong, Shifei, Xiang, Ying, Wu, Long, Xu, Bin, Zhang, Yao, Ma, Xiangyu, Li, Yafei, Song, Zhiyuan, Zhong, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401562/
https://www.ncbi.nlm.nih.gov/pubmed/25884835
http://dx.doi.org/10.1371/journal.pone.0124716
_version_ 1782367161636880384
author Wu, Na
Tong, Shifei
Xiang, Ying
Wu, Long
Xu, Bin
Zhang, Yao
Ma, Xiangyu
Li, Yafei
Song, Zhiyuan
Zhong, Li
author_facet Wu, Na
Tong, Shifei
Xiang, Ying
Wu, Long
Xu, Bin
Zhang, Yao
Ma, Xiangyu
Li, Yafei
Song, Zhiyuan
Zhong, Li
author_sort Wu, Na
collection PubMed
description BACKGROUND: There is growing evidence that indicates the presence of a prothrombotic state in atrial fibrillation (AF). However, the role of hemostatic markers in AF remains inconclusive. METHODS: We conducted a meta-analysis of observational studies to evaluate the association between hemostatic markers and AF. A meta-regression was performed to explore potential sources of heterogeneity. RESULTS: A total of 59 studies met our inclusion criteria for the meta-analysis. For platelet activation, increased circulating platelet factor-4, β-thromboglobulin (BTG) and P-selectin were significantly higher in AF cases compared with controls (standardized mean difference [SMD][95% confidence interval (CI)]: 1.72[0.96–2.49], 1.61[1.03–2.19] and 0.50[0.23–0.77], respectively). For coagulation activation, increased levels of plasma D-dimer, fibrinogen, thrombin-antithrombin, prothrombin fragment 1+2, and antithrombin-III were significantly associated with AF (SMD[95% CI]: 1.82[1.38–2.26], 0.72[0.55–0.89], 0.42[0.13–0.72], 1.00 [0.00–1.99] and 1.38[0.16–2.60], respectively). For fibrinolytic function, tissue-type plasminogen activator and plasminogen activator inhibitor-1 were significantly increased in AF cases compared with controls (SMD[95% CI]: 0.86[0.04–1.67] and 0.87[0.28–1.47], respectively) but the associations became nonsignificant after performing subgroup analysis by anticoagulants treatment status. For endothelial function, increased von Willebrand factor was significantly associated with AF (SMD, 0.79; 95% CI, 0.60–0.99); however, no association was observed for soluble thrombomodulin (SMD, 0.60; 95% CI, -0.13–1.33). CONCLUSIONS: Increased circulating hemostatic factors (PF-4, BTG, P-selectin, D-dimer, fibrinogen, TAT, F1+2, AT- III, and vWf) are significantly associated with AF. Future research is necessary to elucidate the precise mechanism of the prothrombotic state and how hemostatic markers promote thromboembolism in AF.
format Online
Article
Text
id pubmed-4401562
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44015622015-04-21 Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression Wu, Na Tong, Shifei Xiang, Ying Wu, Long Xu, Bin Zhang, Yao Ma, Xiangyu Li, Yafei Song, Zhiyuan Zhong, Li PLoS One Research Article BACKGROUND: There is growing evidence that indicates the presence of a prothrombotic state in atrial fibrillation (AF). However, the role of hemostatic markers in AF remains inconclusive. METHODS: We conducted a meta-analysis of observational studies to evaluate the association between hemostatic markers and AF. A meta-regression was performed to explore potential sources of heterogeneity. RESULTS: A total of 59 studies met our inclusion criteria for the meta-analysis. For platelet activation, increased circulating platelet factor-4, β-thromboglobulin (BTG) and P-selectin were significantly higher in AF cases compared with controls (standardized mean difference [SMD][95% confidence interval (CI)]: 1.72[0.96–2.49], 1.61[1.03–2.19] and 0.50[0.23–0.77], respectively). For coagulation activation, increased levels of plasma D-dimer, fibrinogen, thrombin-antithrombin, prothrombin fragment 1+2, and antithrombin-III were significantly associated with AF (SMD[95% CI]: 1.82[1.38–2.26], 0.72[0.55–0.89], 0.42[0.13–0.72], 1.00 [0.00–1.99] and 1.38[0.16–2.60], respectively). For fibrinolytic function, tissue-type plasminogen activator and plasminogen activator inhibitor-1 were significantly increased in AF cases compared with controls (SMD[95% CI]: 0.86[0.04–1.67] and 0.87[0.28–1.47], respectively) but the associations became nonsignificant after performing subgroup analysis by anticoagulants treatment status. For endothelial function, increased von Willebrand factor was significantly associated with AF (SMD, 0.79; 95% CI, 0.60–0.99); however, no association was observed for soluble thrombomodulin (SMD, 0.60; 95% CI, -0.13–1.33). CONCLUSIONS: Increased circulating hemostatic factors (PF-4, BTG, P-selectin, D-dimer, fibrinogen, TAT, F1+2, AT- III, and vWf) are significantly associated with AF. Future research is necessary to elucidate the precise mechanism of the prothrombotic state and how hemostatic markers promote thromboembolism in AF. Public Library of Science 2015-04-17 /pmc/articles/PMC4401562/ /pubmed/25884835 http://dx.doi.org/10.1371/journal.pone.0124716 Text en © 2015 Wu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wu, Na
Tong, Shifei
Xiang, Ying
Wu, Long
Xu, Bin
Zhang, Yao
Ma, Xiangyu
Li, Yafei
Song, Zhiyuan
Zhong, Li
Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
title Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
title_full Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
title_fullStr Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
title_full_unstemmed Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
title_short Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
title_sort association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401562/
https://www.ncbi.nlm.nih.gov/pubmed/25884835
http://dx.doi.org/10.1371/journal.pone.0124716
work_keys_str_mv AT wuna associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT tongshifei associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT xiangying associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT wulong associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT xubin associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT zhangyao associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT maxiangyu associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT liyafei associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT songzhiyuan associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression
AT zhongli associationofhemostaticmarkerswithatrialfibrillationametaanalysisandmetaregression